Telmisartan 40 mg Tablet

Adult dose

Essential hypertension: Administer 40 mg of Telmisartan orally once daily with water, regardless of food. Depending on the patient, 20 mg once daily may be effective, and if needed, the dose may be increased to 80 mg once daily. Dose increases may show maximum blood pressure-lowering effects 4 to 8 weeks after starting treatment. Risk reduction of cardiovascular disease: Take 80 mg once daily with water.

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Women who are pregnant or may become pregnant, and nursing mothers should not use this medication. Patients with severely impaired liver function or problems with bile secretion should avoid this medication. Individuals with an allergy to this medication or its components should refrain from taking it. Patients with a history of angioedema or who are taking ACE inhibitors or similar medications and have experienced angioedema should be cautious. In diabetic patients with moderate or higher renal impairment, co-administration with specific medications is prohibited. Elderly patients, those with hyperkalemia, and patients with mildly impaired liver function should use this medication carefully. Patients with valvular heart disease or ischemic heart disease, or cerebrovascular disorders should be cautious of excessively low blood pressure. Patients with gastrointestinal diseases may experience more frequent gastrointestinal bleeding or discomfort while taking this medication, so caution is necessary. Patients with renal vascular problems may face risks of worsening renal function, requiring special attention. It is essential to regularly monitor blood pressure, kidney function, and serum potassium levels during treatment to ensure no abnormalities. Due to the strong antihypertensive effect, symptoms of hypotension, dizziness, or syncope should be reported immediately to healthcare professionals. This medication may interact with certain drugs, so inform your healthcare provider about any medications you are currently taking. Particular caution is required when combined with other antihypertensive medications, lithium, diuretics, or non-steroidal anti-inflammatory medications. In case of overdose, hypotension, cardiac arrhythmias, or acute renal failure may occur, requiring emergency treatment. Safety in children and adolescents under 18 years has not been established, and use is not recommended. This medication contains sorbitol, making it unsuitable for patients with certain sugar intolerances. Caution is advised when driving or operating hazardous machinery while on this medication. Store out of reach of children, avoid moisture, and the tablets should be taken out of their packaging just before use.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rash with high fever, blisters, skin peeling, oral/ocular mucosal pain, severe cutaneous reactions, dyspnea or difficulty breathing, asthma attacks, respiratory issues accompanied by cough and fever, jaundice (yellowing of skin or eyes), profound lethargy, liver abnormalities (jaundice), sudden and

Mild side effects

• Upper respiratory infections
• pharyngitis
• sinusitis
• urinary tract infections
• cystitis
• anemia
• thrombocytopenia
• eosinophilia
• hypersensitivity
• hyperkalemia

This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. The recommended storage temperature is room temperature between 1 to 30 degrees Celsius to safely maintain the medication's efficacy.

Appearance

White or whitish oval-shaped tablets

Package unit

30 tablets/box [(10 tablets/Alu-Alu x 3)]